Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Parental involvement in decision making about intracranial pressure monitor placement in children with traumatic brain injury.

Marsh R, Matlock DD, Maertens JA, Rutebemberwa A, Morris MA, Hankinson TC, Bennett TD.

J Neurosurg Pediatr. 2019 Nov 1:1-9. doi: 10.3171/2019.8.PEDS19275. [Epub ahead of print]

PMID:
31675722
2.

TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer.

Park BV, Freeman ZT, Ghasemzadeh A, Chattergoon MA, Rutebemberwa A, Steigner J, Winter ME, Huynh TV, Sebald SM, Lee SJ, Pan F, Pardoll DM, Cox AL.

Cancer Discov. 2016 Dec;6(12):1366-1381. Epub 2016 Sep 28.

3.

The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.

Kumar R, Mickael C, Chabon J, Gebreab L, Rutebemberwa A, Garcia AR, Koyanagi DE, Sanders L, Gandjeva A, Kearns MT, Barthel L, Janssen WJ, Mauad T, Bandeira A, Schmidt E, Tuder RM, Graham BB.

Am J Respir Crit Care Med. 2015 Oct 15;192(8):998-1008. doi: 10.1164/rccm.201410-1820OC.

4.

Novosphingobium and its potential role in chronic obstructive pulmonary diseases: insights from microbiome studies.

Rutebemberwa A, Stevens MJ, Perez MJ, Smith LP, Sanders L, Cosgrove G, Robertson CE, Tuder RM, Harris JK.

PLoS One. 2014 Oct 23;9(10):e111150. doi: 10.1371/journal.pone.0111150. eCollection 2014.

5.

Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection.

Foster RG, Golden-Mason L, Rutebemberwa A, Rosen HR.

Dig Dis Sci. 2012 Feb;57(2):381-9. doi: 10.1007/s10620-011-1997-z. Epub 2011 Dec 20.

PMID:
22183819
6.

Of mice and men, calcineurin inhibitors and hepatitis C.

Rutebemberwa A, Rosen HR.

Liver Transpl. 2012 Jan;18(1):1-4. doi: 10.1002/lt.22458. No abstract available.

7.

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors.

Salgado M, Kirk GD, Cox A, Rutebemberwa A, Higgins Y, Astemborski J, Thomas DL, Thio CL, Sulkowski MS, Blankson JN.

AIDS. 2011 Jan 28;25(3):385-7. doi: 10.1097/QAD.0b013e328341b86a.

8.

High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.

Rutebemberwa A, Ray SC, Astemborski J, Levine J, Liu L, Dowd KA, Clute S, Wang C, Korman A, Sette A, Sidney J, Pardoll DM, Cox AL.

J Immunol. 2008 Dec 15;181(12):8215-25.

9.

Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire.

Wölfl M, Rutebemberwa A, Mosbruger T, Mao Q, Li HM, Netski D, Ray SC, Pardoll D, Sidney J, Sette A, Allen T, Kuntzen T, Kavanagh DG, Kuball J, Greenberg PD, Cox AL.

J Immunol. 2008 Nov 1;181(9):6435-46.

10.

HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.

Rutebemberwa A, Currier JR, Jagodzinski L, McCutchan F, Birx D, Marovich M, Cox JH.

AIDS. 2005 Jul 22;19(11):1165-72.

PMID:
15990569
11.

HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans.

Rutebemberwa A, Auma B, Gilmour J, Jones G, Yirrell D, Rowland S, Imami N, Watera C, Kaleebu P, Whitworth J, Gotch F.

AIDS Res Hum Retroviruses. 2004 Jul;20(7):763-71.

PMID:
15307923
12.

Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.

Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, Nakiyingi J, Rutebemberwa A, Morgan D, Weber J, Gilks C, Whitworth J.

J Infect Dis. 2002 May 1;185(9):1244-50. Epub 2002 Apr 16.

PMID:
12001041

Supplemental Content

Loading ...
Support Center